{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-163990","form_type":"8-K","ticker":"IMA","cik":"0001835579","company_name":"ImageneBio, Inc.","filed_at":"2025-07-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.226783+00:00","generated_at":"2026-05-18T02:33:05.585696+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Ikena Oncology to effect 1-for-12 reverse stock split, rename to ImageneBio, ticker IMA","bullets":["1-for-12 reverse stock split effective July 28, 2025; shares outstanding drop from ~48.2M to ~4M.","Company will rename ImageneBio, Inc., trade under ticker \"IMA\" on Nasdaq, new CUSIP 45175G207.","No fractional shares; cash paid based on July 24 closing price multiplied by fractional share.","Exercise prices and shares underlying equity awards will be proportionally adjusted; par value unchanged.","Stockholders in book-entry or brokerage accounts need no action; beneficial holders contact broker."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-163990","json":"https://secwatch.observer/filing/0001193125-25-163990.json","markdown":"https://secwatch.observer/filing/0001193125-25-163990.md","text":"https://secwatch.observer/filing/0001193125-25-163990.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1835579/000119312525163990/0001193125-25-163990-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1835579/000119312525163990/d21564d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T02:33:05.585696+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}